Literature DB >> 2576425

Association of elevated expression of the c-erbB-2 protein with spread of breast cancer.

Y Yamada1, M Yoshimoto, Y Murayama, M Ebuchi, S Mori, T Yamamoto, H Sugano, K Toyoshima.   

Abstract

We analyzed amplification and expression of the c-erbB-2 gene in human breast cancers. Southern blot hybridization analysis demonstrated amplification of the c-erbB-2 gene in 10 out of 50 tumor DNAs examined. The degree of amplification was three- to twenty-fold relative to normal placenta. The c-erbB-2 protein could be analyzed in 39 tumor tissues of the 50 samples by immuno-blotting, and elevated expression of the c-erbB-2 protein was found in 15 cases. On the other hand, expression of the c-erbB-2 products was not detected in normal breast tissues either by immuno-blotting or by immuno-histological analysis. These data indicate that transcriptional and/or translational activation of c-erbB-2 might occur in some breast cancers in addition to activation by gene amplification. The elevated expression of the c-erbB-2 protein was most strongly correlated with lymph-node metastasis (P less than 0.001), suggesting that c-erbB-2 expression is involved in promotion of the lymph-node metastasis of human breast cancers. Therefore, immuno-histological diagnosis with anti-c-erbB-2 antibody might be useful as an indicator to predict lymph-node involvement in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576425      PMCID: PMC5917922          DOI: 10.1111/j.1349-7006.1989.tb01654.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  22 in total

1.  The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.

Authors:  T Akiyama; C Sudo; H Ogawara; K Toyoshima; T Yamamoto
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

4.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

5.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; T Hirota; S Tsugane; H Yamamoto; N Miyajima; K Toyoshima; T Yamamoto; J Yokota
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

6.  Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.

Authors:  H Lacroix; J D Iglehart; M A Skinner; M H Kraus
Journal:  Oncogene       Date:  1989-02       Impact factor: 9.867

7.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

8.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

Authors:  P P Di Fiore; J H Pierce; M H Kraus; O Segatto; C R King; S A Aaronson
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

9.  Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer.

Authors:  D Zhou; H Battifora; J Yokota; T Yamamoto; M J Cline
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

10.  Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.

Authors:  M H Kraus; N C Popescu; S C Amsbaugh; C R King
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  7 in total

1.  Flow Cytometric Assay of c-erbB-2 Protein in Fine Needle Aspirates of Fresh and Frozen Human Breast Cancer Tissues.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.

Authors:  Y Umekita; N Enokizono; Y Sagara; K Kuriwaki; T Takasaki; A Yoshida; H Yoshida
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk.

Authors:  I Schönborn; W Zschiesche; E Spitzer; C Minguillon; M Möhner; K Ebeling; R Grosse
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.

Authors:  D P Hollywood; H C Hurst
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

5.  Detection of the ligand activity of the c-erbB-2 protein in calf serum.

Authors:  R J Shan; S Matsuda; M Ichino; T Yamamoto
Journal:  Jpn J Cancer Res       Date:  1992-01

6.  Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay.

Authors:  T Watanabe; T Fukutomi; H Tsuda; I Adachi; T Nanasawa; H Yamamoto; K Abe
Journal:  Jpn J Cancer Res       Date:  1993-12

7.  Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; Y Tanaka; T Hirota; S Tsugane; M Shiraishi; K Toyoshima; T Yamamoto; M Terada
Journal:  Jpn J Cancer Res       Date:  1990-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.